Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC) Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Carboplatin
  • Carcinoma, Transitional Cell
  • Cisplatin
  • Nomograms
  • Urologic Neoplasms

abstract

  • We proposed two models for estimating overall survival of patients with metastatic urothelial carcinoma receiving first-line, platinum-based chemotherapy. These nomograms have been developed on real-world patients who were treated outside of clinical trials and may be used irrespective of the chemotherapeutic platinum agent used.

authors

publication date

  • February 2017

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5576985

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2016.09.042

PubMed ID

  • 27726966

Additional Document Info

start page

  • 281

end page

  • 289

volume

  • 71

number

  • 2